GSK

GlaxoSmithKline (GSK) distributed dividends in the last year,in the months of January, April, July e October totaling R$ 8,17. The Dividend Yield for the last 12 months is 4,04%.

Currently, GlaxoSmithKline (GSK) is priced at R$ 215,88, with a P/E of 17,94%, representing a deviation of 11,93% from its historical average P/E. In the last year, the stock showed a variation of -1.17% in its price and distributed R$ 8,17 in dividends, resulting in a Dividend Yield of 4,04%. The total shareholder return was -1,17%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Investing in shares of GlaxoSmithKline (GSK) can be done in two ways: by buying the stock abroad or the BDR in Brazil (if available). The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

The BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

The yield of GlaxoSmithKline (GSK) was 6,06% in the last month, -1,17% in the last year and 60,69% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of R$ 8,70 in dividends, um Dividend Yield de 4,04%.

If you wanted to buy 100 shares of GlaxoSmithKline (GSK) today, the total investment would be based on the current price of R$ 215,88.

If past performance were to repeat, the return on your investment would be:

• In 1 year: R$ 21.335,28
• In 5 years: R$ 34.689,53
• In 10 years: 47.417,73

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.